This real-world study confirms the effectiveness of GLP-1 RAs in improving glycemic control, BWR, and lowering the WC in patients with T2DM and excess weight, with consistent benefits observed across genders, ages, and disease durations, with a greater abdominal fat reduction in males. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.